data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Anavex Life Sciences
(NASDAQ:AVXL)
$9.89
-0.02[-0.20%]
At close: Jun 29
$9.89
00
After Hours: 4:08PM EDT
15 minutes delayed
Day High/Low9.59 - 9.94
52 Week High/Low7.13 - 31.5
Open / Close9.86 / 9.89
Float / Outstanding75.2M / 77.4M
Vol / Avg.446.3K / 890.2K
Mkt Cap765.6M
P/E-
50d Avg. Price8.94
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float75.2M

Anavex Life Sciences (NASDAQ:AVXL), Quotes and News Summary

Anavex Life Sciences (NASDAQ: AVXL)

Day High/Low9.59 - 9.94
52 Week High/Low7.13 - 31.5
Open / Close9.86 / 9.89
Float / Outstanding75.2M / 77.4M
Vol / Avg.446.3K / 890.2K
Mkt Cap765.6M
P/E-
50d Avg. Price8.94
Div / Yield-
Payout Ratio-
EPS-0.14
Total Float75.2M
Benzinga - 6 days ago
Benzinga - May 10, 2022, 7:39AM
Benzinga - Mar 15, 2022, 12:04PM
Benzinga - Feb 9, 2022, 7:19AM
Benzinga - Feb 4, 2022, 7:06AM
Benzinga - Feb 2, 2022, 6:38AM
Benzinga - Feb 1, 2022, 12:53PM
Benzinga - Feb 1, 2022, 9:38AM
Benzinga - Feb 1, 2022, 7:06AM
Benzinga - Feb 1, 2022, 7:03AM
Benzinga - Jan 10, 2022, 8:12AM
Benzinga - Jan 10, 2022, 7:04AM
Benzinga - Jan 4, 2022, 12:52PM
Benzinga - Nov 24, 2021, 9:31AM
Benzinga - Nov 24, 2021, 7:09AM
load more
Sector: Health Care.Industry: Biotechnology
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q2 2022Est.ActualSurprise
EPS-0.140
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Anavex Life Sciences Questions & Answers

Q
How do I buy Anavex Life Sciences (AVXL) stock?
A

You can purchase shares of Anavex Life Sciences (NASDAQ: AVXL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Anavex Life Sciences's (AVXL) competitors?
Q
What is the target price for Anavex Life Sciences (AVXL) stock?
A

The latest price target for Anavex Life Sciences (NASDAQ: AVXL) was reported by Berenberg on Thursday, June 23, 2022. The analyst firm set a price target for 40.00 expecting AVXL to rise to within 12 months (a possible 304.45% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Anavex Life Sciences (AVXL)?
A

The stock price for Anavex Life Sciences (NASDAQ: AVXL) is $9.89 last updated Today at June 29, 2022, 8:00 PM UTC.

Q
Does Anavex Life Sciences (AVXL) pay a dividend?
A

There are no upcoming dividends for Anavex Life Sciences.

Q
When is Anavex Life Sciences (NASDAQ:AVXL) reporting earnings?
A

Anavex Life Sciences’s Q3 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Anavex Life Sciences (AVXL) going to split?
A

There is no upcoming split for Anavex Life Sciences.

Q
What sector and industry does Anavex Life Sciences (AVXL) operate in?
A

Anavex Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.